Assessment of arbovirus co-circulation and associated risk factors among children in Dhaka, Bangladesh

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 559346

Grant search

Key facts

  • Disease

    Zika virus disease, Dengue
  • Start & end year

    2025
  • Known Financial Commitments (USD)

    $85,749.6
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Émile L'Heureux-Hubert
  • Research Location

    Canada
  • Lead Research Institution

    Université de Montréal
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies
  • Research Subcategory

    Disease surveillance & mapping
  • Special Interest Tags

    N/A
  • Study Type

    Non-Clinical
  • Clinical Trial Details

    N/A
  • Broad Policy Alignment

    Pending
  • Age Group

    Children (1 year to 12 years)
  • Vulnerable Population

    Unspecified
  • Occupations of Interest

    Unspecified

Abstract

*Aedes* mosquitoes transmit multiple diseases, including dengue, Zika virus disease, chikungunya, and Japanese encephalitis. Dengue imposes the greatest social burden among these. The endemic areas for these mosquitoes and the diseases they carry are constantly expanding; consequently, finding methods to combat infections transmitted by *Aedes* mosquitoes is becoming increasingly crucial. The current project is part of a study evaluating a community-based approach to preventing dengue infections in Bangladesh. In that study, infection status was assessed by measuring levels of anti-dengue IgG antibodies. However, certain antibodies produced during infections with Zika, chikungunya, and Japanese encephalitis viruses can also react with the dengue virus (cross-reactivity), leading to false-positive results in dengue tests. We will use more specific tests on a smaller subset of the study population. Employing these specific ELISA tests for the various diseases transmitted by *Aedes* mosquitoes will allow us to assess the rate of co-infection with these viruses and the level of cross-reactivity associated with antibodies produced against Zika, chikungunya, and Japanese encephalitis viruses. This project will contribute to identifying and better understanding the risk factors associated with co-infections. Furthermore, it will improve the accuracy of dengue seroconversion measurements by enabling the correction of false-positive results caused by cross-reactions with other arboviruses.